细胞与分子免疫学杂志
細胞與分子免疫學雜誌
세포여분자면역학잡지
2001年
4期
307-309
,共3页
马东初%金伯泉%孙英慧%常奎忠%戴兵%刘亚革%孙忱%贾卫%菅金龙
馬東初%金伯泉%孫英慧%常奎忠%戴兵%劉亞革%孫忱%賈衛%菅金龍
마동초%금백천%손영혜%상규충%대병%류아혁%손침%가위%관금룡
CD226%造血干/祖细胞%巨核细胞%血小板生成素
CD226%造血榦/祖細胞%巨覈細胞%血小闆生成素
CD226%조혈간/조세포%거핵세포%혈소판생성소
目的研究 CD226在造血干 /祖细胞上的表达分布。 TPO诱导胎肝造血干 /祖细胞增殖分化过程中, CD226表达的变化及可能的信号调控途径。方法采用鸡尾酒单抗阴性分离富集 Lin-造血干 /祖细胞,培养于含 TPO的无血清培养体系中,用 PD98059阻断 MAPK信号转导途径,流式细胞仪双荧光分析 CD226、 CD34、 CD41a和 CD61的表达。结果 CD226在 Lin- CD34+细胞和 Lin- CD34-细胞上均有表达。 TPO可诱导 Lin- CD41a- CD226-细胞先分化为 CD41a+ CD226-细胞,再进一步分化为 CD41a+ CD226+细胞, TPO也可诱导 Lin- CD226+细胞表达 CD41a和 CD61。在培养的早期, PD98059可抑制 CD34+ CD226+细胞的减少,在晚期则可抑制 CD41a+ CD226+细胞的增多。结论 CD226与造血干 /祖细胞和巨核细胞的增殖分化可能具有密切的关系。
目的研究 CD226在造血榦 /祖細胞上的錶達分佈。 TPO誘導胎肝造血榦 /祖細胞增殖分化過程中, CD226錶達的變化及可能的信號調控途徑。方法採用鷄尾酒單抗陰性分離富集 Lin-造血榦 /祖細胞,培養于含 TPO的無血清培養體繫中,用 PD98059阻斷 MAPK信號轉導途徑,流式細胞儀雙熒光分析 CD226、 CD34、 CD41a和 CD61的錶達。結果 CD226在 Lin- CD34+細胞和 Lin- CD34-細胞上均有錶達。 TPO可誘導 Lin- CD41a- CD226-細胞先分化為 CD41a+ CD226-細胞,再進一步分化為 CD41a+ CD226+細胞, TPO也可誘導 Lin- CD226+細胞錶達 CD41a和 CD61。在培養的早期, PD98059可抑製 CD34+ CD226+細胞的減少,在晚期則可抑製 CD41a+ CD226+細胞的增多。結論 CD226與造血榦 /祖細胞和巨覈細胞的增殖分化可能具有密切的關繫。
목적연구 CD226재조혈간 /조세포상적표체분포。 TPO유도태간조혈간 /조세포증식분화과정중, CD226표체적변화급가능적신호조공도경。방법채용계미주단항음성분리부집 Lin-조혈간 /조세포,배양우함 TPO적무혈청배양체계중,용 PD98059조단 MAPK신호전도도경,류식세포의쌍형광분석 CD226、 CD34、 CD41a화 CD61적표체。결과 CD226재 Lin- CD34+세포화 Lin- CD34-세포상균유표체。 TPO가유도 Lin- CD41a- CD226-세포선분화위 CD41a+ CD226-세포,재진일보분화위 CD41a+ CD226+세포, TPO야가유도 Lin- CD226+세포표체 CD41a화 CD61。재배양적조기, PD98059가억제 CD34+ CD226+세포적감소,재만기칙가억제 CD41a+ CD226+세포적증다。결론 CD226여조혈간 /조세포화거핵세포적증식분화가능구유밀절적관계。
Aim To investigate the expression of CD226 on Lin- hematopoietic stem/progenitor cells and TPO- induced Lin- cells as well as possible pathway of signal transduction for regulating expression of CD226 by TPO. Methods Lin- hematopoietic stem/progenitor cells isolated from fetal liver mononuclear cells by negative selection with human progenitor enrichment- antibodies cocktail including anti CD2, CD3, CD14, CD16, CD19, CD24, CD56, CD66b mAbs and glycophorin A mAb were incubated in serum- free IMDM supplemented with 15% of mixture of BSA, insulin, transferrin (BIT9500) and 100μ g/L TPO for 18 days. In some experiments, PD98059, a MEK1 inhibitor, was added at a concentration of 20μ mol/L. The expressions of CD226, CD34, CD41a and CD61 were analyzed by using flow cytometry with double- labelling technique. Results CD226 was expressed on both Lin- CD34+ cells and Lin- CD34- cells. TPO firstly induced Lin- CD41a- CD226- cells to differentiate into CD226- CD41a+ /CD61+ cells and then into CD226+ CD41a+ /CD61+ cells. TPO could also induce Lin- CD226+ cells to express CD41a/CD61. PD98095 could suppress decrease in CD34+ CD226+ cells in the early period of the Lin- cell culture and inhibit increment in CD41a+ CD226+ cells in the later period. Conclusion CD226 seems to have a close relation with proliferation and differentiation of hematopoietic stem/progenitor cells and megakaryocytic progenitor cells.